iShares Health Innovation Active ETF (BMED) price, chart and fund profile
Price chart
Fund profile
BMED is actively managed to invest in global equities in the health sciences industry.
- Issuer
- BlackRock Fund Advisors
- Industry
- Healthcare
- Inception
- Sep 29, 2020
- Assets under management
- $13.6M
- Expense ratio
- 0.55%
- Net asset value
- $33.90
- NAV as of
- Aug 28, 2026
- Leverage
- 1×
- Fund page
- www.ishares.com↗
Frequently asked questions
What is iShares Health Innovation Active ETF (BMED)?
BMED is actively managed to invest in global equities in the health sciences industry.
What is BMED's expense ratio?
iShares Health Innovation Active ETF charges an annual expense ratio of 0.55%. The fund is issued by BlackRock Fund Advisors.
How large is BMED?
iShares Health Innovation Active ETF manages $13.6M in assets and has traded since Sep 29, 2020.
How do I buy shares of iShares Health Innovation Active ETF (BMED)?
BMED trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.